STOCK TITAN

[144] Varonis Systems, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Varonis Systems filed a Form 144 notifying a proposed sale of 42,705 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $2,427,352.20. The filing lists 112,047,109 shares outstanding and an approximate sale date of 08/13/2025.

The securities were acquired as Restricted Stock Units on 02/29/2024. The notice also records a prior 10b5-1 sale for Guy Melamed of 51,889 shares on 08/01/2025 with gross proceeds of $2,859,281.08. The filing includes the standard seller representation regarding undisclosed material information and references Rule 10b5-1 plan considerations.

Varonis Systems ha depositato un Form 144 comunicando l'intenzione di vendere 42,705 azioni ordinarie tramite Morgan Stanley Smith Barney, per un valore di mercato complessivo di $2,427,352.20. Il deposito indica 112,047,109 azioni in circolazione e una data approssimativa di vendita di circa 08/13/2025.

I titoli erano stati acquisiti come Restricted Stock Units il 02/29/2024. La comunicazione riporta inoltre una precedente vendita ai sensi del piano 10b5-1 per Guy Melamed di 51,889 azioni il 08/01/2025, con proventi lordi di $2,859,281.08. Il documento include la consueta dichiarazione del venditore relativa all'assenza di informazioni materiali non divulgate e fa riferimento alle considerazioni sul piano previste dalla Regola 10b5-1.

Varonis Systems presentó un Formulario 144 notificando la intención de vender 42,705 acciones ordinarias a través de Morgan Stanley Smith Barney, por un valor de mercado agregado de $2,427,352.20. El registro indica 112,047,109 acciones en circulación y una fecha aproximada de venta de 08/13/2025.

Los títulos fueron adquiridos como Restricted Stock Units el 02/29/2024. La notificación también recoge una venta previa bajo 10b5-1 de Guy Melamed por 51,889 acciones el 08/01/2025, con ingresos brutos de $2,859,281.08. El expediente incluye la habitual declaración del vendedor sobre la ausencia de información material no divulgada y menciona consideraciones relativas a planes conforme a la Regla 10b5-1.

Varonis Systems는 Form 144를 제출해 Morgan Stanley Smith Barney를 통해 보통주 42,705주를 매각할 예정임을 통지했으며, 총 시가액은 $2,427,352.20입니다. 제출 서류에는 유통 주식수 112,047,109주와 예정 매각일(예정) 08/13/2025이 기재되어 있습니다.

해당 증권은 02/29/2024Restricted Stock Units로 취득되었습니다. 공지에는 또한 Guy Melamed의 10b5-1에 따른 이전 매각(주식 51,889주, 08/01/2025)과 총 매각대금 $2,859,281.08이 기록되어 있습니다. 제출 서류는 공개되지 않은 중대한 정보가 없음을 확인하는 표준 판매자 진술을 포함하고 있으며, Rule 10b5-1 계획 관련 사항을 언급합니다.

Varonis Systems a déposé un formulaire 144 signalant l'intention de vendre 42,705 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney, pour une valeur marchande totale de $2,427,352.20. Le dossier indique 112,047,109 actions en circulation et une date de vente approximative au 08/13/2025.

Les titres ont été acquis sous forme de Restricted Stock Units le 02/29/2024. La notification mentionne également une vente antérieure dans le cadre d'un plan 10b5-1 effectuée par Guy Melamed de 51,889 actions le 08/01/2025, pour des produits bruts de $2,859,281.08. Le dépôt comprend la déclaration type du vendeur relative à l'absence d'informations matérielles non divulguées et fait référence aux considérations liées aux plans prévus par la règle 10b5-1.

Varonis Systems hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 42,705 Stammaktien über Morgan Stanley Smith Barney mit einem Gesamtmarktwert von $2,427,352.20 gemeldet wird. Die Einreichung gibt 112,047,109 ausstehende Aktien an und nennt ein voraussichtliches Verkaufsdatum von 08/13/2025.

Die Wertpapiere wurden am 02/29/2024 als Restricted Stock Units erworben. Die Mitteilung verzeichnet außerdem einen früheren 10b5-1-Verkauf durch Guy Melamed von 51,889 Aktien am 08/01/2025 mit Bruttoerlösen in Höhe von $2,859,281.08. Die Einreichung enthält die übliche Verkäufererklärung bezüglich nicht offengelegter wesentlicher Informationen und verweist auf Erwägungen zu Plänen nach Regel 10b5-1.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine insider sale notice of 42,705 shares (~$2.43M); prior 10b5-1 sale noted; impact appears neutral.

The Form 144 shows a proposed disposal of 42,705 common shares valued at $2,427,352.20 via Morgan Stanley Smith Barney LLC with an approximate sale date of 08/13/2025. The filing states 112,047,109 shares outstanding and that the securities were acquired as Restricted Stock Units on 02/29/2024. A prior 10b5-1 sale of 51,889 shares on 08/01/2025 is recorded. Based solely on this disclosure, the item appears to be a compliance notice rather than new operating information.

TL;DR: Filing documents insider transaction under broker and mentions Rule 10b5-1, indicating procedural compliance with disclosure rules.

The notice names Morgan Stanley Smith Barney LLC as the executing broker and includes language about Rule 10b5-1 plan adoption and the seller's certification of no undisclosed material information. The securities were sourced from Restricted Stock Units granted on 02/29/2024, and the filing also records a recent 10b5-1 sale. From a governance perspective, the record shows adherence to required insider disclosure and trading-plan documentation.

Varonis Systems ha depositato un Form 144 comunicando l'intenzione di vendere 42,705 azioni ordinarie tramite Morgan Stanley Smith Barney, per un valore di mercato complessivo di $2,427,352.20. Il deposito indica 112,047,109 azioni in circolazione e una data approssimativa di vendita di circa 08/13/2025.

I titoli erano stati acquisiti come Restricted Stock Units il 02/29/2024. La comunicazione riporta inoltre una precedente vendita ai sensi del piano 10b5-1 per Guy Melamed di 51,889 azioni il 08/01/2025, con proventi lordi di $2,859,281.08. Il documento include la consueta dichiarazione del venditore relativa all'assenza di informazioni materiali non divulgate e fa riferimento alle considerazioni sul piano previste dalla Regola 10b5-1.

Varonis Systems presentó un Formulario 144 notificando la intención de vender 42,705 acciones ordinarias a través de Morgan Stanley Smith Barney, por un valor de mercado agregado de $2,427,352.20. El registro indica 112,047,109 acciones en circulación y una fecha aproximada de venta de 08/13/2025.

Los títulos fueron adquiridos como Restricted Stock Units el 02/29/2024. La notificación también recoge una venta previa bajo 10b5-1 de Guy Melamed por 51,889 acciones el 08/01/2025, con ingresos brutos de $2,859,281.08. El expediente incluye la habitual declaración del vendedor sobre la ausencia de información material no divulgada y menciona consideraciones relativas a planes conforme a la Regla 10b5-1.

Varonis Systems는 Form 144를 제출해 Morgan Stanley Smith Barney를 통해 보통주 42,705주를 매각할 예정임을 통지했으며, 총 시가액은 $2,427,352.20입니다. 제출 서류에는 유통 주식수 112,047,109주와 예정 매각일(예정) 08/13/2025이 기재되어 있습니다.

해당 증권은 02/29/2024Restricted Stock Units로 취득되었습니다. 공지에는 또한 Guy Melamed의 10b5-1에 따른 이전 매각(주식 51,889주, 08/01/2025)과 총 매각대금 $2,859,281.08이 기록되어 있습니다. 제출 서류는 공개되지 않은 중대한 정보가 없음을 확인하는 표준 판매자 진술을 포함하고 있으며, Rule 10b5-1 계획 관련 사항을 언급합니다.

Varonis Systems a déposé un formulaire 144 signalant l'intention de vendre 42,705 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney, pour une valeur marchande totale de $2,427,352.20. Le dossier indique 112,047,109 actions en circulation et une date de vente approximative au 08/13/2025.

Les titres ont été acquis sous forme de Restricted Stock Units le 02/29/2024. La notification mentionne également une vente antérieure dans le cadre d'un plan 10b5-1 effectuée par Guy Melamed de 51,889 actions le 08/01/2025, pour des produits bruts de $2,859,281.08. Le dépôt comprend la déclaration type du vendeur relative à l'absence d'informations matérielles non divulguées et fait référence aux considérations liées aux plans prévus par la règle 10b5-1.

Varonis Systems hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 42,705 Stammaktien über Morgan Stanley Smith Barney mit einem Gesamtmarktwert von $2,427,352.20 gemeldet wird. Die Einreichung gibt 112,047,109 ausstehende Aktien an und nennt ein voraussichtliches Verkaufsdatum von 08/13/2025.

Die Wertpapiere wurden am 02/29/2024 als Restricted Stock Units erworben. Die Mitteilung verzeichnet außerdem einen früheren 10b5-1-Verkauf durch Guy Melamed von 51,889 Aktien am 08/01/2025 mit Bruttoerlösen in Höhe von $2,859,281.08. Die Einreichung enthält die übliche Verkäufererklärung bezüglich nicht offengelegter wesentlicher Informationen und verweist auf Erwägungen zu Plänen nach Regel 10b5-1.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Varonis (VRNS) disclose in the Form 144?

The filing notifies a proposed sale of 42,705 common shares valued at $2,427,352.20 via Morgan Stanley Smith Barney LLC, with an approximate sale date of 08/13/2025.

How were the shares to be sold acquired?

The securities were acquired as Restricted Stock Units on 02/29/2024, and the amount reported for this acquisition is 42,705 shares.

Does the filing show any recent insider sales for VRNS?

Yes. The filing records a 10b5-1 sale by Guy Melamed of 51,889 shares on 08/01/2025 with gross proceeds of $2,859,281.08.

Which broker is named for the proposed sale?

The broker named in the Form 144 is Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza 8th Floor New York NY 10004).

Does the filing include any certification or remarks about undisclosed information?

Yes. The notice includes the seller's representation that they do not know any material adverse information about the issuer that has not been publicly disclosed and references Rule 10b5-1 trading-plan language.
Varonis Sys Inc

NASDAQ:VRNS

VRNS Rankings

VRNS Latest News

VRNS Latest SEC Filings

VRNS Stock Data

6.51B
109.19M
2.6%
110.32%
9.46%
Software - Infrastructure
Services-prepackaged Software
Link
United States
MIAMI